Vimarsana
Biggest News Aggregation in the World

Page 3 - Cellular Immune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Immune Today - Breaking & Trending Today

Protective benefits of the influenza vaccine in reducing risk of Alzheimer's disease - Vimarsana News

Protective benefits of the influenza vaccine in reducing risk of Alzheimer's disease

Alzheimer's disease is a progressive neurological disorder that causes brain atrophy and causes brain cells to die.

Worldwide Clinical Trials, Invitae partner to expedite rare disease trials - Vimarsana News

Worldwide Clinical Trials, Invitae partner to expedite rare disease trials

Worldwide Clinical Trials has entered a strategic collaboration with Invitae to expedite clinical trials for rare disease patients.

A disappointing June for Alzheimer's disease, with setbacks for several products - Vimarsana News

A disappointing June for Alzheimer's disease, with setbacks for several products

Several companies have announced poor results from clinical trials for Alzheimer’s disease therapies this month.

Tighter European trial regulations likely due to Covid-19 research waste - Vimarsana News

Tighter European trial regulations likely due to Covid-19 research waste

With a number of Covid-19 clinical trials in Europe now considered as research waste, sponsors should prepare for more guidelines.

Aerie doses first participant in Phase III dry eye disease therapy trial - Vimarsana News

Aerie doses first participant in Phase III dry eye disease therapy trial

Aerie Pharmaceuticals has announced the dosing of the first participant in the Phase III clinical trial of AR-15512 solution to treat DED.